Adani New Industries raised $394 million from Barclays PLC and Deutsche Bank AG for its solar module manufacturing facility. Ipca Laboratories’ stake purchase in Unichem Laboratories was approved by the Competition Commission. Adani Transmission renamed itself to Adani Energy Solutions. Religare Ent…

Stocks to watch today: July 28, 2023

CCI approves Ipca Laboratories’ acquisition of up to 59.38% of Unichem Laboratories Ltdimited, subject to compliance of voluntary undertakings. Deal announced in April to acquire 33.38% stake for ₹1,034 crore. Open offer to public to acquire additional 26% stake.

CCI approves Ipca Laboratories 59.38% stake buy deal in Unichem Laboratories

A day after Ipca Laboratories agreed to pick up 33-odd per cent in Unichem Laboratories for about ₹1,034 crore, its stock price fell over 10 per cent, reflecting the analyst community’s concern with the deal.

Better than most deals in recent years: Ipca on ‘expensive’ Unichem-buy

Ipca Laboratories has agreed to buy 33.38% of the paid-up equity share capital of Unichem Laboratories for INR1,034.06 crore ($160m). The acquisition is subject to the approval of the Competition Commission of India. Ipca Laboratories board of directors also approved making an open offer to the publ…

Ipca Labs shares tumble 9% on acquisition of stake in Unichem Laboratories

lpca Laboratories has entered into an agreement to pick up 33.38 per cent equity in Unichem Laboratories for ₹1,034.06 crore, with an eye on exporting to developed markets.

Ipca agrees to pick up 33% stake in Unichem

The company has entered into a definitive share purchase agreement for acquisition of 2.35 crore shares at Rs 440 per share.

IPCA Labs To Acquire 33.38% Stake In Unichem Laboratories For Rs 1,034 Crore

IPCA: The shares will be purchased at the cost of Rs 440 per share post the approval from the Competition Commission of India under the Competition Act, 2002

IPCA Labs to buy 33.4% stake in Unichem Laboratories for Rs 1,034 crore

“The Board approved entering into a definitive Share Purchase Agreement (SPA) for the acquisition of 2,35,01,440 fully paid-up equity shares of Rs 21- each, constituting about 33.38% of the paid-up equity share capital of Unichem Laboratories, a listed entity, from one of its promoter shareholders a…

Ipca to acquire 33.4% stake in Unichem Labs for Rs 1,034 crore

Board of Unichem Laboratories appoints director

Unichem Laboratories reports consolidated net loss of Rs 63.93 crore in the December 2022 quarter

Jammu and Kashmir Bank Ltd, Bank of India, Unichem Laboratories Ltd and Union Bank of India are among the other losers in the BSE’s ‘A’ group today, 09 December 2022.

Vakrangee Ltd leads losers in ‘A’ group

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Average profitability - not good, not bad

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Unichem Laboratories Limited is a pharmaceutical company that manufactures active pharmaceutical ingredients (APIs or bulk actives).